Physician

Sreedevi Daggubati, MD

According to 2025 Medicare claims, Sreedevi Daggubati, MD (NPI: 1952373656) practices hematology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Comal, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78130-3162. Daggubati is affiliated with the Main Street Rural Health Hickory ACO LLC (ACO ID: A5334) and Prime Accountable Care East LLC (ACO ID: D0343), participating under both the MSSP and REACH models.

Daggubati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,118 traditional Medicare patients, billed 413,276 HCPCS/CPT codes, and received $5,972,147 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,803 prescription claims across 467 beneficiaries totaling $4,839,087 in drug costs, led by Revlimid (Lenalidomide). DME data shows 16 claims. Open Payments data shows 125 records totaling $82,796. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,742,546 to $5,972,147. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,414,261 to $4,839,087. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,694 to $990.